Adverse drug reactions: definitions, diagnosis, and management.
Edwards IR, Aronson JK.
Lancet. 2000 Oct 7;356(9237):1255-9. doi: 10.1016/S0140-6736(00)02799-9.
Adverse drug reactions.
Montané E, Santesmases J.
Med Clin (Barc). 2020 Mar 13;154(5):178-184. doi: 10.1016/j.medcli.2019.08.007. Epub 2019 Nov 23.
Adverse drug reactions.
Coleman JJ, Pontefract SK.
Clin Med (Lond). 2016 Oct;16(5):481-485. doi: 10.7861/clinmedicine.16-5-481.
Recognition and Management of Severe Cutaneous Adverse Drug Reactions (Including Drug Reaction with Eosinophilia and Systemic Symptoms, Stevens-Johnson Syndrome, and Toxic Epidermal Necrolysis).
Owen CE, Jones JM.
Med Clin North Am. 2021 Jul;105(4):577-597. doi: 10.1016/j.mcna.2021.04.001.
Drugs and the skin: A concise review of cutaneous adverse drug reactions.
Del Pozzo-Magaña BR, Liy-Wong C.
Br J Clin Pharmacol. 2024 Aug;90(8):1838-1855. doi: 10.1111/bcp.15490. Epub 2022 Aug 29.
A Review and Assessment of Drug-Induced Thrombocytosis.
Vo QT, Thompson DF.
Ann Pharmacother. 2019 May;53(5):523-536. doi: 10.1177/1060028018819450. Epub 2018 Dec 10.
The Evolving Profile of Idiosyncratic Drug-Induced Liver Injury.
Fontana RJ, Bjornsson ES, Reddy R, Andrade RJ.
Clin Gastroenterol Hepatol. 2023 Jul;21(8):2088-2099. doi: 10.1016/j.cgh.2022.12.040. Epub 2023 Mar 1.
Drug-Induced Acute Pancreatitis: A Real-World Pharmacovigilance Study Using the FDA Adverse Event Reporting System Database.
Li D, Wang H, Qin C, Du D, Wang Y, Du Q, Liu S.
Clin Pharmacol Ther. 2024 Mar;115(3):535-544. doi: 10.1002/cpt.3139. Epub 2024 Jan 2.
Systematic analysis of sugammadex-related adverse drug reaction signals using FAERS database.
Liu H, Yang Q, Li Z, Yan S, Ming S.
Int J Surg. 2025 Feb 1;111(2):1988-1994. doi: 10.1097/JS9.0000000000002194.
STOPP/START criteria for potentially inappropriate medications/potential prescribing omissions in older people: origin and progress.
O'Mahony D.
Expert Rev Clin Pharmacol. 2020 Jan;13(1):15-22. doi: 10.1080/17512433.2020.1697676. Epub 2019 Nov 30.
